• Ag-appropriations language related to labeling issues
• Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)
• Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access
• Issues Related to Global Health Negotiations as Part of the ongoing TPP Negotiations.

Duration: July 22, 2013 to February 2, 2016

General Issues: Budget/Appropriations, Health Issues, Pharmacy, Trade (Domestic & Foreign), Copyright/Patent/Trademark, Medicare/Medicaid, Food Industry (Safety, Labeling, etc.)

Spending: about $500,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), White House Office, U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA),